2011
DOI: 10.1016/j.arth.2011.03.044
|View full text |Cite
|
Sign up to set email alerts
|

Prosthetic Joint Infection Caused by Gram-Negative Organisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
104
3
7

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 167 publications
(121 citation statements)
references
References 13 publications
7
104
3
7
Order By: Relevance
“…Although several studies, including the present study, have demonstrated that MRSA is reduced in patients with vancomycin, no studies to our knowledge have observed a reduced rate of Gram-positive organism. This finding can likely be explained by the narrower coverage of vancomycin compared with cefazolin and is important because infection with organisms other than Gram-positives such as atypical organisms and Gramnegative infection has been associated with poor treatment outcomes [10,17]. Because of the potential for narrower coverage, another antibiotic can be added such as cefazolin or teicoplanin, which is commonly done in Europe, or monotherapy with antibiotics of broader coverage such as aztreonam, levofloxacin, or clindamycin.…”
Section: Discussionmentioning
confidence: 99%
“…Although several studies, including the present study, have demonstrated that MRSA is reduced in patients with vancomycin, no studies to our knowledge have observed a reduced rate of Gram-positive organism. This finding can likely be explained by the narrower coverage of vancomycin compared with cefazolin and is important because infection with organisms other than Gram-positives such as atypical organisms and Gramnegative infection has been associated with poor treatment outcomes [10,17]. Because of the potential for narrower coverage, another antibiotic can be added such as cefazolin or teicoplanin, which is commonly done in Europe, or monotherapy with antibiotics of broader coverage such as aztreonam, levofloxacin, or clindamycin.…”
Section: Discussionmentioning
confidence: 99%
“…This is evident in an analysis of success in treating gram-negative periprosthetic joint infection at this institution, where the current authors (B.Z. and J.P.) found that a large proportion of patients (26% [six of twenty-three]) did not complete a twostage exchange because of death 53 . Lastly, MRSA is a particularly virulent organism that can cause persistent periprosthetic joint infection and increased cost of treatment 49,53,56 .…”
Section: Periprosthetic J O I N T I N F E C T I O N I N C R E a S E Smentioning
confidence: 94%
“…The effect of periprosthetic joint infection on patient mortality within thirty days is inconclusive, possibly stemming from a type-II error or an indication that no difference exists in the initial insult required in treating periprosthetic joint infection compared with aseptic failure. Other authors have provided anecdotal evidence of increased mortality in patients receiving treatment for periprosthetic joint infection [52][53][54] . Most recently, Berend et al reported 4% mortality within ninety days 52 .…”
Section: Periprosthetic J O I N T I N F E C T I O N I N C R E a S E Smentioning
confidence: 99%
“…Based on the in vitro release experiments, loading with gentamicin-encapsulated liposomes was selected as the best method to test antibacterial properties against E. coli, which is the most frequently isolated microorganism from gram-negative periprosthetic joint infections [52][53][54].…”
Section: As Sintered None Etched Selective Etching (4 Days) Etched+lomentioning
confidence: 99%